Latham & Watkins advised Extra Space Storage on the offering. Extra Space Storage Inc. (NYSE: EXR), a leading owner and operator of self-storage facilities in the...
You must be a Standard 1 Year member to access this content.
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Iovance Biotherapeutics, Latham & Watkins advised the underwriters on the transaction. Iovance Biotherapeutics, Inc. (Iovance), a biotechnology company focused on innovating, developing and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins Advises HilleVax on Pricing of Public Offering of Common Stock. HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Iovance, and Latham & Watkins advised the underwriters. Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) announced the pricing of an underwritten public offering of 20,000,000 shares...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises eFFECTOR Therapeutics in US$7.5 million registered direct offering. eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors (STRIs)...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock. Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Extra Space Storage on the deal, and Morrison Foerster advised Citigroup Global Markets Inc. Extra Space Storage Inc. (NYSE: EXR) and Life...
You must be a Standard 1 Year member to access this content.
Cooley advises Travere Therapeutics, and Latham & Watkins advises the underwriters. Travere Therapeutics, Inc. (Nasdaq: TVTX) has announced the pricing of an underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Mineralys Therapeutics, and Shearman & Sterling advised the underwriters. Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced the pricing of its upsized initial public...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Ligand in the transaction, while Weil, Gotshal & Manges represented APAC. Ligand Pharmaceuticals Incorporated has announced the signing of a definitive merger...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Extra Space in the offering. Extra Space Storage Inc., a leading owner and operator of self-storage facilities in the United States and a...
You must be a Standard 1 Year member to access this content.
